Hindustan Unilever

Hindustan Unilever is predominantly engaged in manufacturing and distributing consumer products mainly in India. Co. operates five main business segments: Soaps and Detergents include soaps, detergent bars, detergent powders, detergent liquids, scourers, etc.; Personal Products include products in the categories of Oral Care, Skin Care (excluding soaps), Hair Care, Deodorants,Talcum Powder, Colour Cosmetics, Ayush services; Beverages include tea and coffee; Package Foods include Branded Staples (Atta, Salt, Bread, etc.), Culinary Products (tomato based products, fruit based products, soups, etc.) and Frozen desserts; Others include Exports, Chemicals, Water business, Infant Care Products.
  • TickerHINDUNILVR
  • ISININE030A01027
  • ExchangeNational Stock Exchange of India
  • SectorPersonal Goods
  • CountryIndia

Analysts

Feasibility Study Results in December to be a Catalyst for this Junior

Feasibility Study Results in December to be a Catalyst for this Junior

Rohit Dokania

Hindustan Unilever's Q2FY20 results (Outperformer) - Outperforming industry growth in tough macro…

Q2FY20 result highlights Revenue grew by 6.7% yoy to Rs98.5bn (est: Rs96.9bn). EBITDA (including other op income) grew by 21% yoy to Rs24.4bn (est: Rs23.8bn), adjusting for benefits accruing from IndAS 116, comparable EBITDA grew by strong 16% yoy to Rs23.4bn and Adjusted PAT grew by 20% yoy to Rs18.3bn (est:Rs19.3bn). Domestic consumer business sales were up 7% yoy with a UVG of 5% (est: 4%). Home care/Personal care/Foods sales grew by 9.4%/5.3% /8.4% yoy. Home care EBIT grew by 21% yoy with margin expansion of 170bps yoy, Personal care EBIT increased by 18% yoy with a margin expansion of...

Krishnan Sambamoorthy

MOSL: HINDUSTAN UNILEVER (Buy)-Earnings momentum strong, reinforcing investment case further

HINDUSTAN UNILEVER: Earnings momentum strong, reinforcing investment case further   (HUVR IN, Mkt Cap USD61.3b, CMP INR2015, TP INR2265, 12% Upside, Buy) Reported net sales grew 6.7% YoY to INR98.5b (our estimate: INR98.8b). EBITDA rose 21% YoY to INR24.4b (16% on a comparable basis after adjusting for Ind-AS 116; our estimate: +14.4% to INR23.1b), while PAT (bei) was up 20.4% YoY to INR18.3b (our estimate: INR16.1b). In contrast to our expectation, the company has started utilizing the corporate tax benefits from 2QFY20 itself, leading to a sharp PAT beat. Domestic consumer business sale...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Int'l Compass: Global Equity Strategy

Squarely in the neutral camp At this point in time the major global indexes (MSCI ACWI, ACWI ex-US, EAFE, EM) have failed to break above their respective resistance levels, leaving us squarely in the neutral camp. • We need to see more from cyclical value. We believe the aforementioned major global indexes are likely to remain below resistance or have limited upside unless and until we see more definitive signs of bottoming within cyclical value areas of the market (e.g., Materials, Energy, banks, major autos & parts, etc.)... see page 2. • Indicators supportive of a neutral outlook. Sever...

1 director sold

A director at Hindustan Unilever Limited sold 10,367 shares at 1,720.000INR and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The...

Feasibility Study Results in December to be a Catalyst for this Junior

Feasibility Study Results in December to be a Catalyst for this Junior